GVBL.BO
Price:
$22.45
Market Cap:
$68.57M
Genomic Valley Biotech Ltd. operates as a development stage company. It engages in the floriculture business. The firm offers leases of ready-made greenhouses for farmers. It also researches about agriculture, stem cell, food biotechnology and environmental biotech product and process development. The company was founded on May 16, 1994 and is headquartered in Bahadurgarh, India.
Industry
Biotechnology
IPO Date
Stock Exchange
BSE
Ticker
GVBL.BO
According to Genomic Valley Biotech Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 62.36. This represents a change of 36.81% compared to the average of 45.58 of the last 4 quarters.
The mean historical PE Ratio of Genomic Valley Biotech Ltd. over the last ten years is 9.78. The current 62.36 PE Ratio has changed 63.64% with respect to the historical average. Over the past ten years (40 quarters), GVBL.BO's PE Ratio was at its highest in in the December 2015 quarter at 587.75. The PE Ratio was at its lowest in in the December 2020 quarter at -146.94.
Average
9.78
Median
18.05
Minimum
-783.67
Maximum
694.20
Discovering the peaks and valleys of Genomic Valley Biotech Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.16%
Maximum Annual PE Ratio = 694.20
Minimum Annual Increase = -300.00%
Minimum Annual PE Ratio = -783.67
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 47.63 | -93.14% |
| 2024 | 694.20 | 6.16% |
| 2023 | 11.09 | -101.42% |
| 2022 | -783.67 | 6.00% |
| 2021 | -12.85 | -151.37% |
| 2020 | 25.01 | -19.15% |
| 2019 | 30.93 | -85.53% |
| 2018 | 213.73 | -300.00% |
| 2017 | -106.86 | 400.00% |
| 2016 | -21.37 | -97.27% |
The current PE Ratio of Genomic Valley Biotech Ltd. (GVBL.BO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
250.97
5-year avg
-8.72
10-year avg
9.78
Genomic Valley Biotech Ltd.’s PE Ratio is greater than Dr. Lalchandani Labs Ltd. (16.71), greater than Nexus Surgical & Medicare Ltd. (15.59), greater than Decipher Labs Ltd. (-1.02), greater than Shamrock Industrial Co. Ltd. (-22.01), greater than Vivanza Biosciences Limited (-28.26), greater than Kobo Biotech Ltd. (-1.15), less than Adline Chem Lab Ltd. (0), greater than Colinz Laboratories Limited (26.91), greater than Tiaan Consumer Ltd. (-1328.61), greater than Naturo Indiabull Ltd. (-4.63),
| Company | PE Ratio | Market cap |
|---|---|---|
| 16.71 | $69.42M | |
| 15.59 | $83.01M | |
| -1.02 | $96.66M | |
| -22.01 | $105.31M | |
| -28.26 | $85.60M | |
| -1.15 | $56.56M | |
| 0 | $48.96M | |
| 26.91 | $124.72M | |
| -1328.61 | $88.01M | |
| -4.63 | $60.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomic Valley Biotech Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genomic Valley Biotech Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genomic Valley Biotech Ltd.'s PE Ratio?
How is the PE Ratio calculated for Genomic Valley Biotech Ltd. (GVBL.BO)?
What is the highest PE Ratio for Genomic Valley Biotech Ltd. (GVBL.BO)?
What is the 3-year average PE Ratio for Genomic Valley Biotech Ltd. (GVBL.BO)?
What is the 5-year average PE Ratio for Genomic Valley Biotech Ltd. (GVBL.BO)?
How does the current PE Ratio for Genomic Valley Biotech Ltd. (GVBL.BO) compare to its historical average?